Nurix Presents Bexobrutideg Data at ASH
Nurix Therapeutics will present new clinical data on its investigational BTK degrader bexobrutideg at the 68th ASH Annual Meeting in December.
California Cancer News
Recent news
November 2, 2026
Drug Boosts Immune Cells Against Melanoma in LabUCLA researchers found temporarily raising p53 activity helped exhausted T cells better target melanoma cells in laboratory tests.
October 26, 2026
California Voters to Decide on $8.4 Billion Cancer BondProposition 38 on the November 3, 2026, ballot proposes massive funding for immunology research.
October 13, 2026
Lawsuit Filed Over PFOA in Carefree Panty LinersPlaintiffs allege manufacturers ignored a California PFAS ban while concealing the presence of harmful chemicals.
October 10, 2026
California Mandated Insurance Coverage for Scalp CoolingGovernor Gavin Newsom signed legislation requiring health plans to cover scalp cooling to prevent hair loss.
September 30, 2026
California Mandated Insurance Coverage for Scalp CoolingGovernor Gavin Newsom signed a law requiring health plans to cover scalp cooling technology for cancer patients.
September 23, 2026
California Study Revealed Cancer Trial DisparitiesResearchers found enrollment gaps based on language, neighborhood, and stage of cancer diagnosis.